scorecardresearch
Wednesday, July 30, 2025
Home Authors Posts by Sumi Sukanya Dutta

Sumi Sukanya Dutta

Sumi Sukanya Dutta
490 POSTS
Sumi Sukanya Dutta is a Senior Assistant Editor with ThePrint. In her 16-year career, she has covered governance and policies but healthcare and pharma sectors are her primary interest. She joined ThePrint in May 2023. Sumi can be reached at sumi.sukanya@theprint.in
COVID-19 vaccines linked to cardiac-related deaths? Siddaramaiah, Biocon founder Shaw spar on X

COVID-19 vaccines linked to cardiac-related deaths? Siddaramaiah, Biocon founder Shaw spar on X

Sumi Sukanya Dutta -
NHRC orders nationwide audit of cath labs by Centre after 7 die in MP at ‘hands of fake cardiologist’

NHRC orders nationwide audit of cath labs by Centre after 7 die in MP at ‘hands of fake cardiologist’

Sumi Sukanya Dutta -
Shefali Jariwala’s death spotlights world of anti-ageing treatments built on big claims, little science

Shefali Jariwala’s death spotlights world of anti-ageing treatments built on big claims, little science

Sumi Sukanya Dutta -
Govt considers low-dose emicizumab for haemophilia, trial finds it more effective than existing treatment

Govt considers low-dose emicizumab for haemophilia, trial finds it more effective than existing treatment

Sumi Sukanya Dutta -
In battle for Indian anti-obesity market, Eli Lilly’s pre-filled pen on one side, Novo Nordisk’s on other

In battle for Indian anti-obesity market, Eli Lilly’s pre-filled pen on one side, Novo Nordisk’s on other

Sumi Sukanya Dutta -
Lancet report highlights gaps in immunisation—no routine vaccine for 14.4 lakh Indian kids in 2023

Lancet report highlights gaps in immunisation—no routine vaccine for 14.4 lakh Indian kids in 2023

Sumi Sukanya Dutta -
Fat-busting blockbuster drug Wegovy launched in India, in pre-filled pens that can be self-administered

Fat-busting blockbuster drug Wegovy launched in India, in pre-filled pens that can be self-administered

Sumi Sukanya Dutta -
Eli Lilly announces trial results for world’s 2nd weekly insulin, aims for launch by year-end

Eli Lilly announces trial results for world’s 2nd weekly insulin, aims for launch by year-end

Sumi Sukanya Dutta -
Made-in-India, low-cost test for bleeding disorders could soon be deployed the world over

Made-in-India, low-cost test for bleeding disorders could soon be deployed the world over

Sumi Sukanya Dutta -
New COVID-19 sub-variants more severe than Omicron? India’s top virus research institute has answers

New COVID-19 sub-variants more severe than Omicron? India’s top virus research institute has answers

Sumi Sukanya Dutta -
123...49Page 2 of 49

Follow us

Copyright © 2025 Printline Media Pvt. Ltd. All rights reserved.